Cardiovascular
Cardiovascular(心血管)
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more
- Acute Phase Reactants(17)
- Angina(14)
- Arrhythmia(85)
- Atherosclerosis(93)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(46)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(131)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(10)
- Endothelium(35)
- Erythrocytes & Hemoglobin(53)
- Heart Failure(32)
- Hypertension(167)
- Hypotension(24)
- Lipoproteins(66)
- Myocardial Contractility(34)
- Myocardial Hypertrophy(22)
- Myocardial Infarction(64)
- Others(53)
- Serum Proteins(11)
- Smooth Muscle Cells(37)
- Storage & Transport(6)
- Stroke(53)
- Vasoconstriction(61)
- Thrombosis(58)
- Vasodilation(146)
Cardiovascular 相关产品(860)
- GC49564Carazolol-d7CAS: 1173021-02-7纯度: >99.00%
An internal standard for the quantification of carazolol
- GC49576Abnormal Cannabidiol-d3CAS: 2649096-15-9纯度: >99.00%
Internal standard for the quantification of abnormal cannabidiol
- GC49638Ambrisentan-d3CAS: 1189479-60-4纯度: >99.00%
An internal standard for the quantification of ambrisentan
- GC49653Ramipril DiketopiperazineCAS: 108731-95-9纯度: >95.00%
A potential impurity found in commercial preparations of ramipril
- GC49677Olmesartan-d6CAS: 1185144-74-4纯度: >99.00%
An internal standard for the quantification of olmesartan
- GC49682Dabigatran-d3CAS: 1246817-44-6纯度: >99.00%
An internal standard for the quantification of dabigatran
- GC49683N-desethyl-N-methyl VardenafilCAS: 224785-87-9纯度: >95.00%
A potential impurity found in commercial preparations of vardenafil
- GC49684Dabigatran-13C-d3CAS: 2967480-55-1纯度: >99.00%
An internal standard for the quantification of dabigatran
- GC49690(3R,5R)-Rosuvastatin (calcium salt)CAS: 1422515-55-6纯度: >95.00%
A potential impurity found in bulk preparations of rosuvastatin
- GC49770Stearic Acid glycidyl ester-d5CAS: 1346598-19-3纯度: >99.00%
An internal standard for the quantification of stearic acid glycidyl ester
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC49511 | Nicorandil N-oxide | 107833-98-7 | >98.00% | |
A metabolite of nicorandil | ||||
| GC49518 | Fluindione | 957-56-2 | >98.00% | |
A vitamin K antagonist | ||||
| GC49543 | Hepcidin-25 (trifluoroacetate salt) | - | >95.00% | |
A peptide hormone | ||||
| GC49556 | Cl-Necrostatin-1 | 862377-51-3 | >95.00% | |
A RIPK1 inhibitor | ||||
| GC49564 | Carazolol-d7 | 1173021-02-7 | >99.00% | |
An internal standard for the quantification of carazolol | ||||
| GC49576 | Abnormal Cannabidiol-d3 | 2649096-15-9 | >99.00% | |
Internal standard for the quantification of abnormal cannabidiol | ||||
| GC49614 | Acenocoumarol-d4 | 2937878-24-3 | >99.00% | |
Acenocoumarol-d4 是氘标记的 Acenocoumarol。 | ||||
| GC49629 | 6β-hydroxy Prednisolone | 16355-29-6 | >95.00% | |
A metabolite of prednisolone | ||||
| GC49634 | Isoflupredone | 338-95-4 | >95.00% | |
A glucocorticoid and mineralocorticoid receptor agonist | ||||
| GC49638 | Ambrisentan-d3 | 1189479-60-4 | >99.00% | |
An internal standard for the quantification of ambrisentan | ||||
| GC49653 | Ramipril Diketopiperazine | 108731-95-9 | >95.00% | |
A potential impurity found in commercial preparations of ramipril | ||||
| GC49671 | 2,3-Oxidosqualene | 7200-26-2 | >90.00% | |
An intermediate in the biosynthesis of sterols | ||||
| GC49677 | Olmesartan-d6 | 1185144-74-4 | >99.00% | |
An internal standard for the quantification of olmesartan | ||||
| GC49679 | Sauvagine (trifluoroacetate salt) | - | >95.00% | |
A neuropeptide hormone | ||||
| GC49682 | Dabigatran-d3 | 1246817-44-6 | >99.00% | |
An internal standard for the quantification of dabigatran | ||||
| GC49683 | N-desethyl-N-methyl Vardenafil | 224785-87-9 | >95.00% | |
A potential impurity found in commercial preparations of vardenafil | ||||
| GC49684 | Dabigatran-13C-d3 | 2967480-55-1 | >99.00% | |
An internal standard for the quantification of dabigatran | ||||
| GC49690 | (3R,5R)-Rosuvastatin (calcium salt) | 1422515-55-6 | >95.00% | |
A potential impurity found in bulk preparations of rosuvastatin | ||||
| GC49706 | Cerberin | 25633-33-4 | >98.00% | |
A cardiac glycoside with cytotoxic and cardiac modulatory activities | ||||
| GC49733 | 1-Stearoyl-2-eicosapentaenoyl-sn-glycero-3-PC | 99264-98-9 | >95.00% | |
A phospholipid | ||||
| GC49738 | Lipid 29 | 2244716-55-8 | >98.00% | |
An ionizable cationic amino lipid | ||||
| GC49762 | Etiocholanedione | 1229-12-5 | >98.00% | |
A neurosteroid | ||||
| GC49770 | Stearic Acid glycidyl ester-d5 | 1346598-19-3 | >99.00% | |
An internal standard for the quantification of stearic acid glycidyl ester | ||||
| GC49777 | Valsartan Acid | 164265-78-5 | >95.00% | |
A valsartan transformation product | ||||